Drugs / L-LV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01358812 | Mar 2010 → Oct 2011 | colorectal cancer | Gruppo Oncologico del Nord-Ovest | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | L-LV | “concomitantly with L-LV 200 mg/sqm over 2 hours followed by 5-FLUOROURACIL” NCT01358812 ↗ |